Fc gamma receptor gene variants associated with rheumatoid arthritisNovember 10, 2005People with a specific combination of variants of two genes, encoding two different receptors for the antibody Fc gamma, are three times more likely to develop rheumatoid arthritis than individuals with different variant combinations. A study published today in the journal Arthritis Research & Therapy confirms previous findings of an association between the Fc gamma Receptor (FCGR) gene family and rheumatoid arthritis (RA). The study shows that a specific variant combination of two FCGR genes on chromosome one, a FCGR3A-FCGR3B haplotype, makes people more susceptible to RA. Ann Morgan, from the University of Leeds, and colleagues from other institutions in the UK studied the frequency of various FCGR haplotypes in a group of UK Caucasians (147 RA patients and 127 healthy individuals acting as controls). Dr Morgan is an Arthritis Research Campaign 'Clinician Scientist Fellow'. One specific FCGR3A-FCGR3B haplotype was found in 31% of RA patients and in 37% of RA patients with a more severe type of RA characterised by lumps around the joints, or nodules. Individuals with 2 copies of this haplotype (homozygous) are three times more likely to develop RA. Homozygous individuals who also have certain variants of human leukocyte antigen (HLA)-DRB1 alleles encoding the 'shared epitope' protein sequence (SE positive), a known risk factor for RA, have a 10 times higher risk of developing RA than SE negative individuals with other FCGR3 variants.
The Fc gamma receptors play important roles in the initiation and regulation of many immunological and inflammatory processes. They also have the ability to bind RA-associated antibodies. This might explain their role in RA pathogenesis. BioMed Central Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Decision Making Protein Malpractice Brain Cells Malaria parasite Cancer Gene Tumor Growth Quantum Computing Parkinson’s Disease Cell Membrane Protein Folding Multiple Myeloma Tomato Anesthesia Telomeres Self-esteem Cigarette Smoke Spinal Cord Health Care Chronic Myeloid Leukemia Wind Power Quasar Public Health Cleft Palate Hurricanes
See More: Science News Tags | |||||||||||||||||||||
|
Related Rheumatoid Arthritis Current Events and Rheumatoid Arthritis News Articles Gene expression findings a step toward better classification and treatment of juvenile arthritis Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). New trigger for chronic inflammation in rheumatoid arthritis discovered A signal molecule made by the human body that triggers the immune system into action may be important in rheumatoid arthritis. Structures from the human immune system's oldest branch shed light on a range of diseases How molecules of the oldest branch of the human immune system have interconnected has remained a mystery. Psoriasis associated with cardiovascular disease and increased mortality The skin disease psoriasis is associated with atherosclerosis (a buildup of plaque in the arteries) characterized by an increased prevalence of ischemic heart disease, cerebrovascular disease, peripheral artery disease and an increased risk of death. Early treatment of systemic onset JIA with anakinra restores the IL-18 response First line treatment with anakinra (an interleukin-1 (IL-1) receptor antagonist), results in a 'good' clinical response (ACRp90) in patients newly diagnosed with systemic onset juvenile idiopathic arthritis (SoJIA), and restores the deficient IL-18 response of natural killer (NK) cells. RA individuals from lower GDP countries keep working despite worse symptoms than richer countries Individuals diagnosed with rheumatoid arthritis (RA) in lower gross domestic product (GDP) countries (GDP below $11,000) are more likely to continue working despite higher disease activity and functional disability scores compared to their counterparts in higher GDP countries (GDP >$24,000). Aussie and Kiwi researchers make double MS genetic discovery Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease. New treatment strategy offers hope to RA patients who failed all other therapies Rheumatoid arthritis (RA) patients who failed to respond to initial treatment with rituximab (RTX) (a chimeric monoclonal antibody against the protein CD20) can still be successfully re-treated with a second course of RTX after six months. Diagnosis of arthritis 5 years earlier in childless women compared to those with children Nulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) an average of 5.2 years before parous women (those who have given birth to children). 63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely Over half (63%) of patients with rheumatoid arthritis (RA) also suffer from psychiatric disorders, with the majority of these (87%) occurring in the depressive spectrum. More Rheumatoid Arthritis Current Events and Rheumatoid Arthritis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||